Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Gamma-Seminoprotein"'
Publikováno v:
پزشکی بالینی ابن سینا, Vol 26, Iss 1, Pp 12-19 (2019)
Background and Objective: Prostate cancer is among the five common cancers in males. It is second cancer in terms of the age-standardized rate (ASR) (ASR=16.6) in Iran. The rs2735839 G/A, an intergenic polymorphism is located on chromosome 19q13.33 a
Externí odkaz:
https://doaj.org/article/806c2c5ccfa141e5893f7161d7520e60
Publikováno v:
پزشکی بالینی ابن سینا, Vol 26, Iss 1, Pp 12-19 (2019)
Background and Objective: Prostate cancer is among the five common cancers in males. It is second cancer in terms of the age-standardized rate (ASR) (ASR=16.6) in Iran. The rs2735839 G/A, an intergenic polymorphism is located on chromosome 19q13.33 a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
埼玉医科大学雑誌 = Journal of Saitama Medical School. 29(3):177-180
In the present report, it was clarified whether or not cancer markers, namely prostate specific antigen (PSA) and gamma-seminoprotein (γ-Sm ), could predict the prognosis for recurrent prostate cancer. Of 139 patients who were diagnosed with prostat
Publikováno v:
埼玉医科大学雑誌 = Journal of Saitama Medical School. 29(3):171-175
The utility of PSA ratio (free/total PSA) in the diagnosis of early-stage prostate cancer is the primary focus of our current research into the interrelationships between various prostate cancer markers. In the present study I evaluated the clinical
Autor:
HIRAO, Yoshihiko, OZONO, Seiichiro, KAGEBAYASHI, Yoriaki, YOSHII, Masato, TANI, Yoshihiro, UEMURA, Hiroaki, MOMOSE, Hitoshi, OKAJIMA, Eigoro, MARUYAMA, Yoshio, KANEKO, Yoshiteru, TABATA, Shoichi, HAYASHI, Yoshiki
Publikováno v:
泌尿器科紀要. 42(10):795-804
1)非前立腺癌泌尿器科疾患687例のうち, 泌尿器科的検査・処置によると考えられる一過性のPSA異常値は38例(5.5%)にみられた. 2)PSAが異常高値を示した例の頻度は, BPHで22.3%, 前立腺癌病期Aで65
Autor:
Tatsuya Chikaraishi, Nobuo Oohashi, Tetsuo Hirano, Takayoshi Demura, Yoshihiko Watarai, Masaki Togashi
Publikováno v:
The Japanese Journal of Urology. 84:1046-1053
Prostate specific antigen (PSA) and gamma-seminoprotein (gamma-Sm) are used as tumor markers of the prostate cancer. However, the serum concentrations of PSA and gamma-Sm are frequently increased in patients with benign prostatic hypertrophy (BPH). W
Publikováno v:
The Japanese Journal of Urology. 82:758-761
Serum gamma-Seminoprotein (gamma-Sm) of 33 patients suffering from urinary retention due to BPH was evaluated. In acute urinary retention gamma-Sm was 17.1 +/- 54.9 ng/ml (N = 33) and its positive rate was 72.7%. After indwelling urethral catherizati
Publikováno v:
泌尿器科紀要. 36(7):783-791
初回治療として内分泌療法を施行した病期D2前立腺癌120例について, PAP, γ-SmおよびPSA値と予後およびマーカー併用の有用性を検討した.1)治療前マーカー値の高低と予後とは, PAP, γ-Smおよ